Aligos Therapeutics, Inc. (ALGS) vs BRIACELL THERAP (BCTX)
- Aligos Therapeutics, Inc. ALGS 4.86 −9.83%
- BRIACELL THERAP BCTX 3.42 −9.28%
Aligos Therapeutics, Inc. and BRIACELL THERAP are both Biotechnology companies. Aligos Therapeutics, Inc. and BRIACELL THERAP are of similar size ($33.7M and $32.8M). Aligos Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; BRIACELL THERAP trades at 1.5×. BRIACELL THERAP has the higher net margin (0.00% vs −241.0%) and the higher return on invested capital (−3,311.0% vs −3,379.3%). Across the 13 metrics below, BRIACELL THERAP leads on 9 and Aligos Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | ALGS | BCTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | (250.63%) | 0.00% | 0.00% |
| Net margin | (241.01%) | 0.00% | 0.00% |
| Free cash flow margin | (299.90%) | 0.00% | 0.00% |
| Return on equity | (113.59%) | (173.55%) | (56.36%) |
| Return on assets | (75.57%) | (139.20%) | (48.04%) |
| Return on invested capital | (3,379.28%) | (3,311.00%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack